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Introduction: 
In the past two decades, there has been increasing awareness and concern about 
endocrine disrupting chemicals (EDCs) which pose a threat to development and reproduction in 
wildlife and human populations. Bisphenol A (BPA), a xenoestrogen that exhibits EDC activity, 
was a commonly used plasticizing agent used in epoxy-resins and in plastic food and beverage 
containers; however, widespread testing demonstrated detrimental effects of acute and chronic 
exposure to this additive (Eladak et al., 2015; Rezg et al., 2014; Duan et al,. 2008). Although the 
effect of BPA is systemic, specific changes have been observed to the cardiovascular system, 
including increased arrhythmia and improper calcium transport and storage mechanisms (Gao & 
Wang, 2014; Qiu et al., 2018).  As a result of numerous studies, there has been a widespread 
push for the removal of BPA from commonly used household items, especially those that are 
used for food and beverage containers. For this reason, structural analogs to BPA, including 
bisphenol F, have been utilized to reduce BPA content while ensuring product quality (Lehmler 
et al., 2018).   
Bisphenol F (BPF) is a structural analog to BPA that 
replaces the two methyl groups at the central carbon with two 
hydrogen atoms, as seen in Figure 1. BPF has since replaced 
BPA in many epoxy-resin and coating materials in processes 
requiring high-strength bindings in addition to many products directly utilized by the consumer, 
including dental sealants, varnishes, and food packaging (Rochester & Bolden, 2015). Although 
this is meant to reduce the quantity of harmful chemicals introduced into the environment and in 
consumer products, several studies have investigated the EDC activity of BPF. These studies 
have suggested that BPF exhibits effects to the same order of magnitude of BPA and, in some 
instances, acts as a more powerful EDC than BPA in certain body systems (Eladak et al., 2015; 
Figure 1: Structures of BPA and BPF 
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Rochester & Bolden, 2015). BPF is found in human urine at levels comparable to BPA, and this 
quantity is expected to rise due to the continuing increase of BPF in products (Rochester & 
Bolden, 2015; Lehmler et al., 2018). Thus, in order to protect human and environmental health, 
the systemic effects of BPF exposure must be investigated in the coming years.  
Zebrafish (Danio rerio) are an effective model for vertebrate and human development. 
Zebrafish demonstrate a high gene conservation rate compared to humans and have been used in 
numerous toxicological studies (Yang et al., 2018). Zebrafish express proteins and molecular 
signaling pathways that are similar to humans (Yang et al., 2018). Experiments utilizing 
zebrafish have shed light on chemical interactions within vertebrates that can be extended to 
human health, including studies that have elucidated genes for Parkinson’s (de Fonseca et al., 
2013), examined effect of nicotine on proteins (Suen et al., 2013), and investigated the 
cardiovascular response to new pharmaceutical products (Lee et al., 2013).  
 The purpose of this study was to observe the effect of bisphenol F addition to water 
inhabited by zebrafish embryos on their cardiac output and stroke volume. I hypothesized that 
bisphenol F will decrease the overall cardiac output in zebrafish embryos and will lead to a 
higher death rate overall. 
Materials and Methods: 
Wild-type zebrafish (Danio rerio) housed at the University of Akron Research Vivarium 
were utilized as the breeding stock to obtain for this experiment. Standard housing conditions 
were maintained for adult zebrafish at a temperature of 28 ± 0.5°C. A breeding box was 
introduced the in the evening prior to the dark cycle; breeding occurs just prior to the beginning 
of the light cycle in adults. Embryos were collected, rinsed, and transferred to laboratory B235 
for containment and exposures.  
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Embryos were exposed to three treatment groups in this experiment: dechlorinated water, 
dechlorinated water with the addition of ethanol, and dechlorinated water with the addition of 
ethanol and BPF. Following collection of embryos from breeding boxes, flasks containing the 
various treatment group solutions were prepared. Previous work found that 1% ethanol does not 
significantly increase mortality rates in zebrafish embryos (Duan et al., 2008). Control flasks 
were prepared using only dechlorinated water, ethanol-exposure flasks were prepared to a 
concentration of 1% ethanol, and BPF flasks were prepared to a concentration of 1% ethanol 
with a BPF concentration of 50 µg/L. Embryos (n = 58) were divided among treatment groups (n 
= 31 for BPF, n = 19 for control, and n = 18 for ethanol).  After 24 hours post-exposure (hpe) 
and 48 hpe, five to ten second videos of each embryo heart were taken using an inverted 
microscope using at high speed camera at 125 frames per second. All embryos were euthanized 
prior to 72 hours post fertilization using 0.5% MS-222. ImagePro software was used to measure 
ventricle length and width at systole and diastole in order to find ventricle volume. Ventricle 
volume was determined according to the method of (Bagatto & Burggren, 2005) using the 
formula for a prolate spheroid  
4𝜋𝑎𝑏
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where a was the length of the longitudinal axis of the ellipse and b was the length of the width of 
the ellipse. Stroke volume was found by calculating the difference between the systolic and 
diastolic volumes. Heart beat was measured by calculating the number of frames between five or 
ten beats of the heart and using camera frame rate to measure beats per minute. Cardiac output 
was determined by multiplying stroke volume by heart rate for each embryo. As a result of using 
several treatment flasks, analysis of variance (ANOVA) and Tukey HSD analysis were 
performed to determine statistical significance (p < 0.05) among treatment groups. 
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Results: 
 As seen in Figure 2 and Figure 3, no statistical difference was found between any 
treatment groups at either 24 hpe (p = 0.616 and p = 0.1813) or 48 hpe (p = 0.2409 and p = 
0.0551).   
 The BPF treatment group was found to have a statistically lower mean stroke volume at 
24 hpe (p < 0.001) with a mean of 9.51±0.86 nL. Compared to stroke volume of control embryos 
at 15.71±1.14 nL and ethanol at 14.70±1.14 nL, the BPF group exhibited a 35% reduction. 
However, as seen in Figure 4, at 48 hpe, the ethanol group had a significantly lower mean stroke 
volume of 21.43±4.98 nL. This group experienced a 42% reduction in stroke volume compared 
to the BPF treatment group at 37.53±4.07 nL and the control treatment group at 37.09±3.32 nL 
(p = 0.0274).  
 As seen in Figure 5, at 24 hpe, the BPF treatment group did not statistically differ from 
either treatment group, but the ethanol group had a mean heart rate with a mean of 96.80±2.84 
bpm, 12% higher than to the control group with a mean of 85.67±2.84 bpm (p = 0.0177). At 48 
hpe, the ethanol treatment had a significantly lower mean heart rate with 78.25±6.14 bpm while 
BPF had a mean of 143.33±5.01 bpm and control mean a mean of 137.28±4.09 bpm (p < 
0.0001).  
 The BPF treatment group had a statistically lower mean cardiac output at 24 hpe as 
compared to the other treatment groups (p = 0.0014). As seen in Figure 6, mean cardiac outputs 
were 43% lower in the BPF group at 907±94 nL/min while mean cardiac outputs for other 
groups were 1394±124 nL/min for control and 1414±124 nL/min for ethanol. At 48 hpe, the 
ethanol group was significantly lower than the other groups with a mean of 2127±752 nL/min as 
compared to 5414±614 nL/min and 5109±501 nL/min for BPF and control groups, respectively 
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(p = 0.0032). The mean cardiac output of the ethanol group was 86% lower than the other 
treatment groups.  
 
 
Figure 2 displays the mean systolic volume in nanoliters of each treatment group at 24 and 48 
hpe. No significant difference was found among any of the treatment groups at either 
developmental stage (p = 0.616 and p = 0.2409, respectively). Error bars illustrate standard error. 
Samples sizes at 24 hpe were BPF (n = 31), control (n = 19), and ethanol (n = 18). At 48 hpe, 
they were: BPF (n = 20), control (n = 18), and ethanol (n = 10) 
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Figure 3 exhibits the mean diastole volume in nanoliters of each treatment group at 24 and 48 
hpe. No significant difference was found among any of the treatment groups at either 
developmental stage (p = 0.1813 and p = 0.0551, respectively). Error bars illustrate standard 
error. Samples sizes at 24 hpe were BPF (n = 31), control (n = 19), and ethanol (n = 18). At 48 
hpe, they were: BPF (n = 20), control (n = 18), and ethanol (n = 10) 
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Figure 4 displays the mean stroke volume in nanoliters of each treatment group at 24 and 48 
hpe. Significant differences were found among treatment groups at both developmental stages (p 
< 0.001 and p = 0.0274, respectively) as denoted by asterisks. Error bars illustrate standard error. 
Samples sizes at 24 hpe were BPF (n = 31), control (n = 19), and ethanol (n = 18). At 48 hpe, 
they were: BPF (n = 20), control (n = 18), and ethanol (n = 10) 
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Figure 5 illustrates the mean heart rate in beats per minute of each treatment group at 24 and 48 
hpe. Statistical differences were observed among treatment groups at 24 and 48 hpe (p = 0.0177 
and p < 0.0001, respectively) as denoted by asterisks. Error bars illustrate standard error. 
Samples sizes at 24 hpe were BPF (n = 31), control (n = 19), and ethanol (n = 18). At 48 hpe, 
they were: BPF (n = 20), control (n = 18), and ethanol (n = 10) 
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Figure 6 displays the mean cardiac outputs in nanoliters per minute of each treatment group at 
24 and 48 hpe. Significant differences were found among treatment groups at both 
developmental stages (p = 0.0014 and p = 0.0032, respectively) as denoted by asterisks. Error 
bars illustrate standard error. Samples sizes at 24 hpe were BPF (n = 31), control (n = 19), and 
ethanol (n = 18). At 48 hpe, they were: BPF (n = 20), control (n = 18), and ethanol (n = 10) 
Discussion:   
 At 24 hpe, the mean stroke volume of the BPF experimental group was statistically lower 
compared to both the control and ethanol groups (p < 0.001). Figure 4 illustrates that the control 
and ethanol groups did not exhibit a significant difference while the BPF group had a lower 
mean stroke volume. Similarly, noted in Figure 6, as cardiac output is directly correlated to 
stroke volume, the BPF treatment group had a significantly lower mean cardiac outputs (p = 
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0.0014). This 35% reduction in stroke volume and cardiac output correlates to the results of other 
studies that found decreased cardiac parameters following exposure to BPA (Duan et al., 2008; 
Cypher et al., 2015). It also correlates with studies that have shown that the analog BPA causes a 
300% increase in premature ventricular beats that would impede proper cardiac muscle function 
(Yan et al., 2011).   
 Mean heart rates for the ethanol treatment groups at 24 hpe were significantly higher than 
only the control group as seen in Figure 5 (p = 0.018). The BPF treatment group did not differ 
significantly from either group. Some studies have found that heart rate does not differ under the 
addition of xenoestrogens (Soares et al., 2009) while others have demonstrated that BPA causes 
up to a 42% decrease in heart rate (Cypher et al., 2015). In this light, it is possible that ethanol 
may have influenced the cardiovascular rhythm of the embryos that caused an approximately 
50% decrease in stroke volume and cardiac output parameters compared to controls. 
 Observations at 48 hpe produced a differing condition of results. The ethanol treatment 
group was observed to have a significantly lower value for all three parameters of mean stroke 
volume, heart rate, and cardiac output (p = 0.0274, 0.0001, and 0.0032, respectively). 
Conversely, the BPF and control groups exhibited almost no difference between their parameters 
as seen in Figure 4, Figure 5, and Figure 6. It must be noted that 70% mortality was observed in 
the ethanol treatment group at 48 hpe. In one subgroup, all members that were alive at 24 hpe 
were found dead, while in another subgroup, all embryos were found near death with bodily 
pigmentation beginning to darken substantially, an indicator of tissue and organism death. As 
such, heart rates of ethanol-treated zebrafish at 48 hpe may be skewed downward as 
cardiovascular function in the dying organisms was beginning to fail. As such, 1% ethanol did 
have a significant effect upon mortality and development of zebrafish embryos contrary to other 
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studies (Duan et al., 2008; Bilotta et al., 2004). Death rates of the BPF and control groups were 
between 6 and 10%.  
 Overall, these results may confirm the results of (Cypher et al., 2018) which found that 
cardiac parameters experience a significant decrease in the presence of hypoxia and a 
xenoestrogen; therefore, it is possible that experimental design did not provide adequate oxygen 
circulation. Ethanol is known to cause mortality in zebrafish embryos and hypoxia is a common 
environmental stressor for these organisms; thus, the combination of these factors may have 
increased mortality exponentially (Bilotta et al., 2004).  
 Future studies are needed to continue work on BPF to investigate its effect on 
cardiovascular parameters. Although studies have been conducted to demonstrate the effect of 
BPA on heart disease, few studies have been conducted on the specific effects of its analog BPF 
on the function of cardiac systems. Due to a low sample size (n = 58 among all treatment groups; 
n = 31 for BPF), observations on the statistical differences between treatment groups may exhibit 
some bias in this study. Larger sample sizes and repetitions of experiments should be conducted 
to verify the findings of this study and to shed more light on the problem of bisphenol A 
substitutes. As BPF continues to be used more ubiquitously in consumer products, more research 
must be done to ensure its safety.  
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